Facebook
Twitter
LinkedIn
Forward
15th Annual Inflammatory Bowel Disease: The Art and Science in the Diagnosis and Treatment 2022
Join us in-person or virtually for IBD Boston 2022.
Each year, the Boston IBD conference brings top gastroenterology specialists from North America together with up-and-coming Boston area specialists for a 1.5 day CME/CNE program. This program is designed to stimulate conversations about how to initiate practice changes within the IBD healthcare team in in the diagnosis and management of patients with Crohn's disease (CD) and ulcerative colitis (UC). Through keynote talks, panel discussions and breakout sessions, you will be challenged to develop innovative strategies to improve the quality of life for your patients while prolonging clinical remission. The city of Boston provides an excellent backdrop for this educational and networking experience – we hope you can join us in person – or – if you prefer – from the comfort of your home or office through a virtual live stream.
What past attendees have said about the Boston IBD Meeting:
"Excellent conference! Case discussions were good."
"Wonderful and as always highly educational! Provides useful information we can apply to our practice daily."
Keynote Speakers
Jean-Frédéric Colombel, MD
Professor of Medicine
Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center and the Leona M. and Harry B. Helmsley Charitable Inflammatory Bowel Disease Research Center
Icahn School of Medicine at Mount Sinai, New York, NY, USA
Gilaad Kaplan, MD, MPH, FRCPC, AGAF, FCAHS
Professor of Medicine
Division of Gastroenterology and Hepatology, Departments of Medicine and Community Health Sciences,
O’Brien Institute for Public Health and Snyder Institute for Chronic Diseases,
Cumming School of Medicine, University of Calgary
Sandra Quezada, MD, MS, AGAF (She/Her)
Associate Dean for Admissions
Associate Dean for Faculty Diversity and Inclusion
Associate Professor of Medicine
University of Maryland School of Medicine
Acknowledgement
Education program is provided by:
- Boston University School of Medicine | Continuing Medical Education
In conjunction with:
- Boston Medical Center
- Beth Israel Deaconess Medical Center
- Brigham and Women’s Hospital
- Boston Children’s Hospital
- Lahey Hospital & Medical Center
- Massachusetts General Hospital
- Tufts Medical Center
- UMass Memorial Medical Center
Supported by educational grants from:
- Pfizer, Inc.
- Takeda Pharmaceuticals U.S.A., Inc.
- Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
- Supported, in part, by an educational grant from Ferring Pharmaceuticals, Inc
Supported by exhibits from:
- Abbvie
- Bristol Myers Squibb
- Janssen Immunology
- Kate Farms
- Nestlé Health Science
- Organon
- Pfizer, Inc.
- Takeda Pharmaceuticals U.S.A., Inc
Endorsed by the Crohn’s & Colitis Foundation
Target Audience
This course is designed for the entire IBD healthcare team including gastroenterologists, pediatric gastroenterologists, colorectal surgeons, NP/PAs, nurses. pharmacists and other health care professionals caring for patients with CD and UC.
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Discuss emerging agents for IBD in terms of therapeutic target, safety and efficacy data, and place in therapy.
- Critically assess targets of mucosal healing used in treat-to-target strategies and the evidence that exists to support the use of these strategies in IBD patients.
- Differentiate the benefits and risks of biologic treatments in patients with IBD.
- Recognize the value and role of therapeutic drug monitoring.
- Explore the complex interplay of IBD and fertility concerns, pregnancy, and sexual function in women’s health.
- Promote and advocate for the patient’s role and voice in IBD shared decision-making to drive a more patient-oriented treatment approach.
- Review the role of diagnostic imaging and endoscopic biopsy in the diagnosis and monitoring of CD and UC.
- Identify the most current approaches to the management of postoperative recurrence in CD.
- Describe the medical and surgical approaches in patients with severe UC and pouchitis.
- Identify issues specific to LGBTQ patients with IBD.
View last year's talk "IBD: The Pandemic Year in Review"
By: Athos Bousvaros, MD
Additional Information
| Attachment | Size |
|---|---|
 IBD22 Brochure Sept.pdf | 3.46 MB |
Friday September 23, 2022
12:00pm
Registration (in person attendees)
12:45pm Welcome and Introduction including remembrance of Joel Weinstock, MD
12:50pm
Keynote: Environmental Factors: Their Role in IBD Disease Pathogenesis. Can We Prevent IBD?
Gilaad Kaplan, MD, MPH, FRCPC, AGAF, FCAHS
1:35pm
Contemporary Management of Acute Severe Colitis
Ashwin Ananthakrishnan, MD, MPH
2:00pm
Radiology and IBD
Martin P. Smith, MD
2:25pm
Panel: Medical and Surgical Management of Complex Crohns Disease
Moderator: Adam Cheifetz, MD
Panelists: Sarah N. Flier, MD, Gilaad Kaplan, MD, MPH, FRCPC, AGAF, FCAHS, Jason Hall, MD, MPH, Matthew Shields, MD
3:25pm
Break
3:45 pm
Management of Short Bowel Syndrome
Christopher P. Duggan, MD, MPH
4:10pm
Panel: Sexual Function and Fertility
Moderator: Sonia Friedman, MD, FACG
Panelists: Janis Heidi Fox, MD, Martin N. Kathrins, MD, Angela Kuhnen, MD, FACS, FASCRS, Meghan Z. Markowski, PT, DPT
4:55pm
Fireside Chat: How to Advocate for Your Patients with Insurance Companies
Athos Bousvaros, MD, MPH, Jo Stewart RPh, MS, CSP
5:30pm
Adjourn
Saturday, September 24, 2022
7:30am
Registration/Breakfast for in person attendees
8:00am
Introduction
8:05am
Keynote: What Management of IBD Will Look Like 15 Years in The Future
Jean-Frédéric Colombel, MD
8:50am
Pathology and IBD
Jeffrey Goldsmith, MD
9:15am
CBT Behavioral Therapy
Sarah Ballou, PhD
9:40am
Panel: Positioning of the Biologics
Moderator: Matthew Hamilton, MD
Panelists: Jean-Frédéric Colombel, MD, Laurie Grossberg, MD, Paul A. Rufo, MD, MMSc
10:25am
Break
10:45am
Panel: Colon Dysplasia
Moderator: Bharati Kochar, MD, MS
Panelists: Thomas E Cataldo, MD FACS, FASCRS, D. Punyanganie de Silva, MBBS, MPH, MRCP(UK), Kristen Farwell, MD
11:30am
Liver Disease in IBD
Kathleen Viveiros, MD
11:55am
Very Early Onset IBD: Diagnosis and Treatment
Jodie Ouahed, MDCM, MMSc, FRCPC, FAAP
12:20pm
Break (Lunch for in person attendees)
1:20pm
Keynote: Social Determinants of Health in Patients with IBD
Sandra Quezada, MD, MS, AGAF
2:05pm
Transition to breakouts
2:10pm
Difficult Case Breakouts
Jess Kaplan, MD
Hamed Khalili, MD
Alexander N. Levy, MD
Loren Rabinowitz, MD
Sharmeel Wasan, MD, FACG
Rachel W. Winter, MD, MPH
3:10pm
Break
3:40pm
LGBTQ and IBD
Victor Chedid, MD, MS
4:05pm
How Genetics and Biomarkers Can Predict Response
Sean Fine MD, MS
4:30pm
Panel Medical and Surgical Management of Complex UC
Moderator: Rachel W. Winter, MD, MPH
Panelists:Jess Kaplan, MD, David A. Kleiman, MD, Msc, FACS, FASCRS, L. Campbell Levy, MD
5:15pm
Adjourn
Renowned as one of the best hotels in Boston, MA, this property offers an incomparable location and an elevated level of service. The Boston Common hotel provides a selection of rooms and suites, all refurbished and redesigned, with a wealth of amenities and dining options. Boston Park Plaza is superbly located amid shopping, transportation, restaurants and historic destinations that inspire discovery.
A block of rooms has been reserved at the Boston Park Plaza with an arrival date of Thursday, September 22nd and a departure date of Sunday September 25, 2022.. All guest rooms are run-of-house and guestroom types cannot be guaranteed. The type of room will depend on your length of stay.
Room rates start at $269 (single or double occupancy) + plus applicable taxes (currently 16.45%).
The room block will be open until 5:00PM local time on September 1st or until it sells out, whichever happens first. After this date, reservations will be accepted on a space and rate available basis.
Individual reservations can be called in to 617-379-7129 and reference the group name IBD Boston 2022.
Online reservations can be made here: https://book.passkey.com/e/50344845
Rates cannot be changed at check in or check out for guests who fail to identify their affiliation at the time the reservation is made. Cancellations of individual reservaions will be accepted up until 3:00pm three days prior to arrival date, at which point, a one night non-refundable deposit will be charged to teh credit care of the guest on file.
By staying at the conference venue, you help the host organizations meet their contractual obligations. Please take this into consideration when making your accommodation decision. Thank you!
Speakers
Sarah Ballou, PhD
Assistant Professor of Medicine
Harvard Medical School
Director of GI Psychology Services
Beth Israel Deaconess Medical Center
Thomas E Cataldo, MD FACS, FASCRS
Beth Israel-Deaconess Medical Center
Program Director in Colorectal Surgery
Assistant Professor of Surgery
Harvard Medical School
Victor Chedid, MD, MS
Assistant Professor of Medicine
Senior Associate Consultant
Mayo Clinic
Jean-Frédéric Colombel, MD
Professor of Medicine
Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center and the Leona M. and Harry B. Helmsley Charitable Inflammatory Bowel Disease Research Center
Icahn School of Medicine at Mount Sinai, New York, NY, USA
D. Punyanganie de Silva, MBBS, MPH, MRCP(UK)
Assistant Professor of Medicine, Harvard Medical School
Associate Physician
Crohn’s & Colitis Center, Brigham and Women’s Hospital
Christopher P. Duggan, MD, MPH
Senior Physician, Division of Gastroenterology, Hepatology and Nutrition
Director, Center for Nutrition
Medical Director, Center for Advanced Intestinal Rehabilitation
Boston Children’s Hospital
Samuel Meltzer, MD Professor of Pediatrics, Harvard Medical School
Kristen Farwell MD
Assistant Professor of Medicine
Tufts University School of Medicine
Physician
Lahey Hospital and Medical Center
Sean Fine MD, MS
Director, Inflammatory Bowel Disease Center
Assistant Professor of Medicine
Warren Alpert Medical School of Brown University
Sarah N. Flier, MD (she/her)
Assistant Professor | Harvard Medical School
Director | Gastroenterology Fellowship Training Program
Fellowship Program Director | Center for Inflammatory Bowel Disease
Director of Quality Assurance | Division of Gastroenterology
Janis Heidi Fox, MD
Assistant Professor, Harvard Medical School
Department of Obstetrics and Gynecology
Division of Reproductive Endocrinology and Infertility
Center for Infertility and Reproductive Surgery
Brigham and Women's Hospital
Jeffrey D. Goldsmith, MD
Director of Gastrointestinal Pathology, Boston Children’s Hospital
Consultant, Gastrointestinal Pathology, Brigham and Women’s Hospital
Associate Professor of Pathology, Harvard Medical School
Laurie Grossberg, MD
Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Matthew Hamilton, MD
Assistant Professor of Medicine, Harvard Medical School
Director of Translational Research
Director of the IBD fellowship Program and IBD Education Programs
Brigham and Women’s Hospital Crohn's and Colitis Center
Gilaad Kaplan, MD, MPH, FRCPC, AGAF, FCAHS
Professor of Medicine
Division of Gastroenterology and Hepatology, Departments of Medicine and Community Health Sciences,
O’Brien Institute for Public Health and Snyder Institute for Chronic Diseases,
Cumming School of Medicine, University of Calgary
Jess Kaplan, MD
Assistant Professor of Pediatrics
Harvard Medical School
Pediatric Gastroenterologist
MassGeneral for Children
Martin Kathrins, MD
Assistant Professor of Surgery
Harvard Medical School
Associate Surgeon
Brigham and Women’s Hospital
Hamed Khalili, MD
Assistant Professor of Medicine, Harvard Medical School
Gastroenterologist, Massachusetts General Hospital
David A. Kleiman, MD, Msc, FACS, FASCRS
Staff Surgeon, Division of Colon & Rectal Surgery
Lahey Hospital & Medical Center
Assistant Professor of Surgery
Tufts University School of Medicine
Bharati Kochar, MD, MS
MGH Crohn’s and Colitis Center
Angela Kuhnen, MD, FACS, FASCRS
Surgical Director, Inflammatory Bowel Disease Center
Program Director, Colon and Rectal Surgery Residency
Assistant Professor of Surgery Lahey Hospital & Medical Center
Alexander N. Levy, MD
Assistant Professor
Tufts University School of Medicine
Gastroenterologist
Tufts Medical Center, Division of Gastroenterology & Hepatology
L. Campbell Levy, MD
Gastroenterology and Hepatology
Dartmouth Hitchcock Medical Center and Clinics
Meghan Z. Markowski, PT, DPT
Clinical Specialist in Pelvic Health Physical Therapy
Board Certified Women’s Health Clinical Specialist
Board Certified in Pelvic Muscle Dysfunction Biofeedback
Brigham and Women’s Hospital
Jodie Ouahed, MDCM, MMSc, FRCPC, FAAP
Assistant Professor
Harvard Medical School
Staff Physician, Pediatric Gastroenterology, Hepatology, and Nutrition
Boston Children's Hospital
Sandra Quezada, MD, MS, AGAF (She/Her)
Associate Dean for Admissions
Associate Dean for Faculty Diversity and Inclusion
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
University of Maryland School of Medicine
Loren Rabinowitz, MD
Instructor in Medicine
Beth Israel Deaconess Medical Center and Harvard Medical School
Attending Physician, Inflammatory Bowel Disease Center
Beth Israel Deaconess Medical Center
Martin P. Smith, MD
Director, Community MRI
Body MRI and Abdominal Imaging
Beth Israel Deaconess Medical Center
Jo Stewart RPh, MS, CSP
Specialty Pharmacy Manager
Boston Children’s Pharmacy
Boston Children’s Hospital
Kathleen Viveiros, MD
Instructor, Harvard Medical School
Gastroenterology, Hepatology and Endoscopy
Brigham and Women’s Hospital
Rachel W. Winter, MD, MPH
Instructor in Medicine
Harvard Medical School
Associate Physician
Brigham and Women’s Hospital
Planning Committee
Ashwin Ananthakrishnan, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Director, Crohn’s and Colitis Center
Massachusetts General Hospital
Athos Bousvaros, MD, MPH
Course Co-Director
Professor of Pediatrics, Harvard Medical School
Associate Director
IBD Center Associate Chief, Division of Gastroenterology
Boston Children’s Hospital
Robert Burakoff, MD, MPH, FACG, AGAF
Professor of Medicine
Weill Cornell Medical College
Vice Chair of Medicine,
Ambulatory Services
Department of Medicine
Weill Cornell Medical College
Professor Emeritus, Harvard Medical School
Adam Cheifetz, MD
Director of the Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Professor of Medicine at Harvard Medical School
Susan Dybowski, MSN, CPNP
CNE Course Advisor
Pediatric IBD Nurse Practitioner
Boston Children’s Hospital
Sonia Friedman, MD, FACG
Course Co-Director
Professor of Medicine
Harvard Medical School
Associate Physician
Brigham and Women’s Hospital
Kathleen Gura, PharmD, BCNSP, FASHP, FPPAG
Pharmacy Clinical Research Program Manager, Pharmacy
Boston Children's Hospital
Assistant Professor of Pediatrics, Harvard Medical School
Jason F. Hall MD MPH FACS FASCRS
Surgeon-in-Chief, Tufts Medical Center
Benjamin Andrews Chair for the Department of Surgery
Tufts University School of Medicine
Jhenane Joseph, RN, BSN
Registered Nurse
Boston Medical Center
Randall Pellish, MD
Director, Inflammatory Bowel Disease Center
Division of Gastroenterology
Lahey Hospital & Medical Center
Paul A. Rufo, MD, MMSc
Assistant Professor of Pediatrics, Harvard Medical School
Program Director, HMS Fellowship in Pediatric Gastroenterology
Associate Director for Inclusion, Fenwick Institute for Pediatric Health Equity and Inclusion
Matthew Shields, MD
Assistant Professor of Pediatrics
Division of Pediatric Gastroenterology
UMass Memorial Medical Center
Carmela A. Townsend, DNP, MS/MBA, RN
Lead Nurse Planner
Continuing Medical Education Office
Boston University School of Medicine
Sharmeel Wasan, MD, FACG
Course Co-Director
Associate Professor of Medicine, Boston University School of Medicine
Fellowship Program Director, Section of Gastroenterology
Boston Medical Center
CME Program Manager: Claire P. Grimble, CMP
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 11.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.*
By attending this activity and providing your ABIM or ABP number and Date of Birth, you authorize BUSM CME office to report your information to the ACCME so that we may process your MOC Part II credit on your behalf.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours: 12 of which 6 is eligible for pharmacology credit.
According to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN.
Specific Category Approved: 1
Hours Approved: 12.08
Tracking Number: ABCGN22_056
The University of Rhode Island College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is an application-based educational activity.
Day 1 UAN: 0060-9999-22-056-L01-P 4.25 Contact Hours (0.425 CEUs)
Day 2 UAN: 0060-9999-22-057-L01-P 7.25 Contact Hours (0.725 CEUs)
Available Credit
- 12.08 ABCGNAccording to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN. Specific Category Approved: ABCGN22_056 Hours Approved: 12.08
- 11.00 ABIM Medical Knowledge
- 11.00 ABP Lifelong Learning and Self-Assessment
- 11.50 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 11.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 12.00 ANCC
- 6.00 ANCC Pharmacology
- 11.50 Participation
Supported by exhibits from:
- Abbvie
- Bristol Myers Squibb
- Janssen Immunology
- Kate Farms
- Nestlé Health Science
- Organon
- Pfizer, Inc.
- Takeda Pharmaceuticals U.S.A., Inc
Supported by educational grants from:
- Pfizer, Inc.
- Takeda Pharmaceuticals U.S.A., Inc.
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Supported, in part, by an educational grant from Ferring Pharmaceuticals, Inc
Price
| MD/DO | $199 |
| Allied Healthcare (RN, PA, NP) | $149 |
| Fellows/Resident/Student in person (virtual is free - email cgrimble@bu.edu to sign up) | $100 |
| BUSM Alumni | $160 |
Please note the per person costs are the same for both in-person or virtual attendance.
To pay by check, please create an account and email us at cme@bu.edu or call 617-358-5005 and we will assist you.
Cancellation Policy
Substitutions may be made at any time without an additional charge. Refunds, less an $50 administrative fee, will be issued for all cancellations received two weeks prior to the start of the meeting. Should cancellation occur within the two-week window, a credit will be issued, not a refund. Credits will be honored for up to two years. “No shows” are subject to the full course fee. Cancellations/substitution(s) must be made in writing. Refunds or credits will not be issued once the conference has started. This course is subject to change or cancellation. You may switch your in-person/virtual attendance by 9/20/22.
If you need to cancel your registration, please click here.
Special Services / Dietary Needs
Boston University strives to be accessible, inclusive and diverse in our facilities, programming and academic offerings. Your experience in this event is important to us. If you have a disability, require communication access services for the deaf or hard of hearing, or believe that you require a reasonable accommodation for another reason please contact the BUSM-CME Office at least 3 weeks prior to event to discuss your needs. For in person meetings with meals, we will work to accommodate dietary requests (including, but not limited to: kosher, vegetarian, low cholesterol, and low sodium) received in writing at least three weeks prior to the start of the conference. Please contact us at cme@bu.edu
Sharing You Information Through Participant Lists:
If you checked "Yes" to sharing your information on the participant list, we only share name, degree, organization, city and state. Checking "Yes" indicates we may share your name with exhibitors from commercial entities (ineligible companies) including pharmaceutical and medical device companies.
Please Note
The conference organizers may take pictures or record videos during the conference. In registering for the conference, you acknowledge that BUSM may photograph you during the meeting, and you agree that we may include images of yourself, intact or in part, for conference promotional activities or other related endeavors. This material may also appear on the conference's website or associated social media outlets. If you do not wish to be photographed, please let the BUSM representative onsite know
Our COVID-19 Safety Precautions are as follows:
We are committed to creating a safe conference environment. Mask-wearing is not required, but remains optional, for events. We also strongly encourage all attendees to be vaccinated with boosters, as eligible. Any participant with symptoms that could be related to COVID-19 should not engage in group activities and seek medical advice.
We will continue to follow local, state, and Federal event and meeting protocols to ensure the health and safety of all attendees, staff, and the local community and will update all attendees on these protocols as we get closer to the meeting date.
Unauthorized Registration Sites
Registration for courses managed by BUSM-CME can only be completed through our website at https://cme.bu.edu. Course registrations made through other sites cannot be honored. BUSM-CME is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com
Please report any unauthorized websites or solicitations for registrations to cme@bu.edu.
Boston University School of Medicine seeks to ensure equitable treatment of every person and to make every attempt to resolve grievances in a fair manner. Please submit a written grievance to: Claire Grimble, cme@bu.edu, 617-358-5005. Grievances would receive, to the best of our ability, corrective action in order to prevent further problems.